A Meeting of the Board of Directors of Sandu Pharmaceuticals Limited was duly convened on Tuesday, 11th August 2026 at 04:00 p.m. and concluded at 5.15 p.m.
1. Financial Results
The Board approved the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2026, along with the Limited Review Report issued by the Statutory Auditors, M/s. Dileep & Prithvi Chartered Accountants. The auditors issued an unmodified conclusion on the results.
Key Financial Figures for Quarter Ended June 30, 2026:
- Revenue from Operations: ₹1,640.62 lakh
- Total Expenses: ₹1,604.57 lakh
- Profit Before Tax: ₹36.05 lakh
- Current Tax: ₹5.37 lakh
- Deferred Tax: ₹3.86 lakh
- Profit for the Period: ₹2.8 lakh
- Other Comprehensive Income: ₹15.52 lakh
- Total Comprehensive Income: ₹38.35 lakh
- Basic & Diluted EPS: ₹0.37 per equity share (face value ₹10.00 per share)
Comparative Figures:
- Quarter Ended June 30, 2025: Revenue ₹1,721.85 lakh, Profit ₹23.4 lakh, EPS ₹0.04
- Quarter Ended March 31, 2026: Revenue ₹1,671.67 lakh, Profit ₹23.3 lakh, EPS ₹0.23
The company operates in one business segment: "Ayurvedic Proprietary Medicines."
2. Annual Report Components
The Board approved the Directors' Report, Management Discussion and Analysis Report, Corporate Governance Report, Secretarial Audit Report and other reports forming part of the Annual Report for FY 2025-26.
3. Record Date
The Board approved the closure of the Register of Members and Share Transfer Books from Friday, September 4, 2026 to Friday, September 11, 2026 (both days inclusive) for the ensuing Annual General Meeting. The Record Date for determining eligibility for the proposed dividend for FY26 is Friday, September 4, 2026.
4. Fund Utilisation Statement
The Board took note of the Statement of Utilisation and Statement of Deviation(s) in utilisation of funds for the quarter ended June 30, 2026, as required under Regulation 32 of SEBI LODR.
5. Annual General Meeting
The Board approved convening the 41st Annual General Meeting on Friday, September 11, 2026, at 4:30 P.M. (IST) through Video Conferencing/Other Audio-Visual Means.
6. Material Related Party Transactions
The Board recommended obtaining member approval at the AGM for continuation of Material Related Party Transactions with M/s. Sandu Brothers Private Limited.
7. Appointment of Statutory Auditors
Based on the Audit Committee's recommendation, the Board approved and recommended the appointment of M/s. Dave & Dave, Chartered Accountants (Firm Registration No. 102163W) as Statutory Auditors for a first term of five consecutive years. The appointment would commence from the conclusion of the ensuing AGM until the conclusion of the AGM in 2031, subject to member approval.
Auditor Profile: Established in 1989, based in Mumbai with 2 partners, 2 associates and 10 staff members. Holds valid Peer Review Certificate No. 020259 (valid until 31 March 2028). The firm has extensive experience in statutory, internal, management, stock and tax audits, along with corporate law and secretarial compliances. The firm is not related to any Directors, Key Managerial Personnel, or Promoters of the company.